Skip to main content

Featured

5 Things to Know Today — September 27, 2026

  Sunday, September 27, 2026  |  MoneySavings.ca A milestone in the Canada-US trade war hits at midnight, the Bank of Canada's rate decision is now a near-coin-flip, and Canada's economic pivot to China is showing real results. Here are the five things that matter for your wallet today. 01 OF 05 The US Alcohol Import Ban Takes Effect Tonight at Midnight At 12:01 a.m. Eastern tonight, the United States stops accepting new shipments of packaged Canadian beer, wine, cider, and spirits. The ban was signed by President Trump on September 8 under Section 338 of the Tariff Act of 1930, escalating the trade dispute beyond the 50% tariffs that took effect on August 22. Everything already on US store shelves stays there and can still be sold — the ban stops restocking, not consumption. Goods imported before tonight but not yet cleared through customs remain subject to the 50% duty rather than the ban. Bulk spirits shipped in containers over four litres are exempt; consumer-sized bo...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments